Therapeutische gebieden

Autoimmune Type 1 Diabetes

The Type 1 Diabetes (T1D) field is evolving. Recognition of the presymptomatic stages in T1D is growing.^1-4  The clinical benefits of early detection of T1D are being highlighted.^3-4 Programmes focusing on early detection through testing and screening for presymptomatic autoimmune T1D are increasingly offered to risk populations and the general population.^1,2

Glycaemic Targets and Vascular Complications in Type 2 Diabetes: What Are the Thresholds?

Summary of Zoungas S, et al. Diabetologia. 2012;55:636–643.

When to Initiate Basal Insulin?

Practical Guidance based on the 2022 ADA/EASD Guidelines.

Vaccin gerelateerde materialen bestellen

Informatiematerialen nasale poliepen

Atopisch Eczeem Beeldbank

Deze beeldbank eczeem biedt u uiteenlopende illustraties, van anatomie en pathologie tot diagnostiek en stadia van atopisch eczeem. De illustraties kunt u kosteloos gebruiken voor uw presentaties, scholingen en patiëntenvoorlichting. Mocht u op zoek zijn naar een illustratie die niet wordt aangeboden in deze beeldbank, dan kunt u bij ons het verzoek indienen om deze op maat voor u te laten maken. Wij wensen u veel gebruiksgemak toe met deze service.

DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice

3rd of December 2024

EADV Spring Symposium

EADV 2024

The Deliver-G study

DELIVER-G: Real-world analysis in insulin-naïve adults with T2DM on GLP-1 RA ± OAD(s), intensifying their therapy by starting basal insulin and discontinuing GLP-1 RA, or adding basal insulin to ongoing GLP-1 RA, or initiating a FRC product and discontinuing current GLP-1 RA†¹

Webcast: Targeting COPD with type 2 inflammation - emerging biologic landscape

Explore the Latest Insights in COPD Management and Biologic Therapies.

Polyp Gossip – Episode 2

We explore the impact of smell impairment and its connection to CRSwNP. Featuring insights from our hosts and a special guest, we uncover pathways to recovery and improved quality of life.